Crossject: Information on the number of voting rights and shares

Crossject, a company specializing in the development of medicines for emergencies, has communicated the total number of voting rights and shares making up its share capital as of May 31, 2024.

As of May 31, 2024, the company's share capital consisted of 36,763,256 shares. The total number of theoretical voting rights attached to these shares was 45,014,346, while the number of exercisable voting rights was 44,883,574.

These figures take into account shares held by the company itself as well as those registered under its liquidity contract, which are deprived of voting rights. In total, 130,772 shares were deprived of voting rights.